A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing

Sponsor
novoGI (Industry)
Overall Status
Unknown status
CT.gov ID
NCT01880918
Collaborator
(none)
200
3
9
66.7
7.4

Study Details

Study Description

Brief Summary

The proposed study is a post marketing, observational, retrospective data collection intended to gather and record data on patients treated with the ColonRing device in routine clinical practice at 4-6 centers. The data will assist in future evaluating the performance of the ColonRing device in regards to the creation of a colorectal anastomosis in Low Anterior Resection procedures.

Hypothesis: The performance of the ColonRing, determined by the rate of complications, will be within the acceptable range reported in the literature for alternative treatment modalities.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Time Perspective:
Retrospective
Official Title:
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Study Start Date :
Oct 1, 2012
Anticipated Primary Completion Date :
Jun 1, 2013
Anticipated Study Completion Date :
Jul 1, 2013

Arms and Interventions

Arm Intervention/Treatment
ColonRing

The ColonRing device is intended to be used for the creation of intestinal anastomoses in colorectal surgery in both open and laparoscopic surgeries. This indication is within the currently cleared indication of the ColonRing device, which has been cleared by the US FDA and carries the CE Mark for use throughout the alimentary trct for the creation of circular end-to-end, side-to-end or side-to-side anastomosis.

Outcome Measures

Primary Outcome Measures

  1. The rate of anastomotic leakage. [6 weeks after the procedure]

    Anastomotic leakage is defined as evidence of a defect in the intestinal wall integrity at the anastomotic site leading to a communication between the intra and extra luminal compartments.

Secondary Outcome Measures

  1. Rate of other device related complications and measures during hospitalization and post procedure. [6 weeks after the procedure.]

    The Following complications will be examined: Bleeding. Stricture (either clinical evidence of a stricture or the inability to pass a 12 mm sigmoidoscope through the anastomosis in a procedure that does not include a diversion). Septic complication (including wound infection, pelvic infection, peritonitis, abscess) Readmission, re-operation, death within two months of the procedure Extra colonic complications (including urinary infection, urinary retention, DVT, pneumonitis, pulmonary embolism, cardiac, injury to other organs - e.g. spleen, ureter) The following post operative measures will be reported: Hospitalization duration (two dates will be recorded: ready for discharge and discharge). The latter noting where the patient was discharged to - e.g. nursing home or home. First day to first postoperative flatus. First day to first postoperative bowel movements. First day of first postoperative toleration of liquids and solids (time to "keeping them down")

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patient was > 18 years old at time of procedure

  2. Patient underwent a technically successful open or laparoscopic colorectal, Low Anterior Resection procedure with the creation of an anastomosis using the ColonRing™

  3. Patient treated in routine clinical practice

  4. Patient underwent his/her first follow-up visit within two months post-surgery

Exclusion Criteria:

No exclusion criteria have been defined for this data collection.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Florida Hospital, Center for Colon & Rectal Surgery Atlamonte Springs Florida United States 32701
2 18308 Murdock Circle, Suite 108 Port Charlotte Florida United States
3 CoxHealth Hospital, Colorectal Department Springfield Missouri United States 65807

Sponsors and Collaborators

  • novoGI

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
novoGI
ClinicalTrials.gov Identifier:
NCT01880918
Other Study ID Numbers:
  • RETROPRESS, CLPR-43-11-01
First Posted:
Jun 19, 2013
Last Update Posted:
Jun 19, 2013
Last Verified:
Jun 1, 2013

Study Results

No Results Posted as of Jun 19, 2013